Pain is common in cancer patients, particularly in the advanced stage of disease when the
prevalence is estimated to be more than 70%[1], contributing to poor physical and emotional …

Objective: Patient's trust in their physician is crucial for desirable treatment outcomes such
as satisfaction and adherence. In oncology, trust is possibly even more essential, due to the …

According to a systematic review of the literature, pain prevalence ranges from 33% in
patients after curative treatment to 59% in patients on anticancer treatment and to 64% in …

Poor pain assessment is cited as one barrier to the adequate treatment of cancer pain. The
identification of relevant psychosocial factors may improve the assessment of chronic cancer …

There is both a nociceptive and neuropathic component of bone cancer pain. In bone cancer
pain, there is frequently a continual afferent drive of sensory nerve fibers that induces a …

Palliative care aims to improve quality of life for people with serious illness and their families.
One potential barrier to palliative care uptake is inaccurate knowledge and/or negative …

BACKGROUND Researchers sometimes undertake qualitative research with randomised
controlled trials (RCTs) of health interventions. OBJECTIVES To systematically explore how …

Most patients with advanced or metastatic cancer experience pain and despite several
guidelines, undertreatment is well documented. A multicenter, open-label, prospective, non …

Background: Pain is one of the most frequent symptoms among patients with metastatic
cancer, yet little is known about what patients with advanced cancer want from the …

Clinical research on acupuncture in cancer care is a new and challenging field in oncology.
The evidence currently available has suggested that acupuncture is a safe and effective …